PERLETTI, GIANPAOLO
 Distribuzione geografica
Continente #
NA - Nord America 14.963
EU - Europa 8.718
AS - Asia 6.429
SA - Sud America 847
AF - Africa 341
OC - Oceania 164
Continente sconosciuto - Info sul continente non disponibili 14
Totale 31.476
Nazione #
US - Stati Uniti d'America 14.658
IT - Italia 4.269
SG - Singapore 1.826
UA - Ucraina 1.252
CN - Cina 1.209
VN - Vietnam 800
TR - Turchia 685
BR - Brasile 672
SE - Svezia 663
HK - Hong Kong 642
GB - Regno Unito 470
IE - Irlanda 388
DE - Germania 354
FI - Finlandia 346
FR - Francia 309
IN - India 270
RU - Federazione Russa 210
CA - Canada 176
AU - Australia 134
ID - Indonesia 111
IQ - Iraq 109
PK - Pakistan 97
BD - Bangladesh 95
IR - Iran 95
NG - Nigeria 95
MX - Messico 89
JP - Giappone 71
EG - Egitto 66
ES - Italia 66
KR - Corea 66
PL - Polonia 57
AR - Argentina 55
NL - Olanda 54
ZA - Sudafrica 51
TH - Thailandia 49
TW - Taiwan 49
BE - Belgio 48
MY - Malesia 43
GR - Grecia 40
PH - Filippine 40
NP - Nepal 29
NZ - Nuova Zelanda 27
EC - Ecuador 26
PE - Perù 24
DZ - Algeria 23
CZ - Repubblica Ceca 22
JO - Giordania 22
AT - Austria 21
BG - Bulgaria 20
CO - Colombia 20
UG - Uganda 20
GH - Ghana 19
RS - Serbia 19
KE - Kenya 17
PT - Portogallo 17
SA - Arabia Saudita 17
MA - Marocco 16
UZ - Uzbekistan 16
IL - Israele 15
VE - Venezuela 15
CH - Svizzera 14
RO - Romania 14
CL - Cile 13
EU - Europa 13
AE - Emirati Arabi Uniti 10
LT - Lituania 10
QA - Qatar 10
TN - Tunisia 10
YE - Yemen 10
AL - Albania 9
HU - Ungheria 8
MD - Moldavia 8
SK - Slovacchia (Repubblica Slovacca) 8
UY - Uruguay 8
DK - Danimarca 7
ET - Etiopia 7
BO - Bolivia 6
PY - Paraguay 6
SN - Senegal 6
AZ - Azerbaigian 5
CU - Cuba 5
DO - Repubblica Dominicana 5
LB - Libano 5
PS - Palestinian Territory 5
CR - Costa Rica 4
GT - Guatemala 4
HN - Honduras 4
JM - Giamaica 4
LK - Sri Lanka 4
BH - Bahrain 3
FJ - Figi 3
KW - Kuwait 3
LU - Lussemburgo 3
MM - Myanmar 3
NI - Nicaragua 3
OM - Oman 3
SD - Sudan 3
SI - Slovenia 3
SV - El Salvador 3
TT - Trinidad e Tobago 3
Totale 31.439
Città #
Milan 2.828
Fairfield 1.592
Ashburn 1.224
San Jose 1.052
Singapore 1.050
Woodbridge 1.031
Jacksonville 953
Chandler 821
Houston 801
Seattle 683
Wilmington 616
Hong Kong 593
Cambridge 566
Ann Arbor 493
Dublin 374
Princeton 368
Dearborn 343
Nyköping 337
Dallas 315
Izmir 300
Beijing 282
Rome 258
The Dalles 227
Boardman 225
Chicago 213
Dong Ket 195
Lauterbourg 181
Council Bluffs 176
Ho Chi Minh City 168
Como 167
New York 133
Los Angeles 131
San Mateo 122
San Diego 116
Hanoi 106
Santa Clara 86
Ogden 77
London 75
Orem 60
Tokyo 55
Guangzhou 54
Helsinki 54
São Paulo 53
Abuja 49
Montreal 43
Shanghai 43
Jakarta 39
Munich 39
Verona 39
Chennai 37
Sydney 37
Warsaw 37
Bangkok 36
Brisbane 36
Mexico City 35
Nanjing 35
Toronto 35
Hefei 34
Kocaeli 33
San Francisco 32
Washington 32
Brooklyn 31
Kunming 31
Manchester 31
Cairo 30
Sulaymaniyah 29
Phoenix 28
Denver 27
Atlanta 26
Lahore 25
Baghdad 24
Mumbai 24
Pioltello 24
Rio de Janeiro 24
Moscow 23
Johannesburg 22
Shenzhen 22
Amman 21
Lagos 21
Portland 21
Rozzano 21
Tianjin 21
Brussels 20
Nuremberg 20
Stockholm 20
Boston 19
Frankfurt am Main 19
Hangzhou 19
Pune 19
Kampala 18
Ankara 17
Athens 17
Brno 17
Haiphong 17
Kuala Lumpur 17
Manila 17
Melbourne 17
Norwalk 17
Taipei 17
Adelaide 16
Totale 21.074
Nome #
Nutraceutical treatment and prevention of benign prostatic hyperplasia and prostate cancer 970
Infectious complications of endourological treatment of kidney stones: A meta-analysis of randomized clinical trials 683
Drug-induced gynecomastia: A systematic review and meta-analysis of randomized clinical trials 672
Serenoa repens and its effects on male sexual function. A systematic review and meta-analysis of clinical trials 447
Effect of alpha-adrenoceptor antagonists on sexual function. A systematic review and meta-analysis 306
Prostatic calcifications are associated with a more severe symptom burden in men with type II chronic bacterial prostatitis 273
5-Lipoxygenase and anandamide hydrolase (FAAH) mediate the antitumor activity of cannabidiol, a non-psychoactive cannabinoid. 260
The Integral Theory System Questionnaire: an anatomically directed questionnaire to determine pelvic floor dysfunctions in women 248
Risk of urinary stone formation associated to proton pump inhibitors: a systematic review and metanalysis 244
Serenoa repens and Pygeum Africanum in the treatment of BPH 242
Aminoglycoside antibiotics for NIH category II chronic bacterial prostatitis: A single-cohort study with one-year follow-up 234
Analysis of chromosomal radiosensitivity of healthy BRCA2 mutation carriers and non-carriers in BRCA families with the G2 micronucleus assay 232
ANALYSIS OF CALCIUM-DEPENDENT PROTEIN-KINASE-C ISOFORMS IN THE EARLY STAGES OF DIETHYLNITROSAMINE-INDUCED RAT HEPATOCARCINOGENESIS 230
Efficacy of overactive neurogenic bladder treatment: A systematic review of randomized controlled trials 228
Eradication of Chlamydia trachomatis parallels symptom regression in chronic bacterial prostatitis patients treated with a fluoroquinolone-macrolide combination. 228
Discrepancies between in silico and in vitro data in the functional analysis of a breast cancer-associated polymorphism in the XRCC6/Ku70 gene. 224
Role in anxiety behavior of the endocannabinoid system in the prefrontal cortex 223
Multimodal therapy for category III chronic prostatitis/chronic pelvic pain syndrome in UPOINTS phenotyped patients 221
Combined effect of polymorphisms in Rad51 and Xrcc3 on breast cancer risk and chromosomal radiosensitivity 220
National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI) symptom evaluation in multinational cohorts of patients with chronic prostatitis/chronic pelvic pain syndrome. 216
Are oxygen radicals responsible for the acute cardiotoxicity of doxorubicin? 213
Effect of HIF-1 modulation on the response of two- and three-dimensional cultures of human colon cancer cells to 5-fluorouracil 209
Characterization of the c.190T>C missense mutation in BRCA1 codon 64 (Cys64Arg). 209
Polymorphisms in nonhomologous end-joining genes associated with breast cancer risk and chromosomal radiosensitivity. 207
Increased chromosomal radiosensitivity in asymptomatic carriers of a heterozygous BRCA1 mutation 207
Anti-infective treatment of bacterial urinary tract infections. 206
Chronic bacterial prostatitis: enterococcal disease? 206
A new approach to the direct detection of free radicals in the intact myocardium. 206
Activity of Serenoa repens, lycopene and selenium on prostatic disease: evidences and hypotheses. 202
Efficacy and safety of second-line agents for treatment of metastatic castration-resistant prostate cancer progressing after docetaxel. A systematic review and meta-analysis 202
Fluoroquinolone-macrolide combination therapy for chronic bacterial prostatitis: retrospective analysis of pathogen eradication rates, inflammatory findings and sexual dysfunction. 201
Antimicrobials in urogenital infections. 200
Natural history of human papillomavirus infection in non-vaccinated young males: low clearance probability in high-risk genotypes 199
A severely symptomatic case of anaerobic chronic bacterial prostatitis successfully resolved with moxifloxacin therapy. 197
Computer-assisted quantitative assessment of prostatic calcifications in patients with chronic prostatitis 197
Comparative analysis of molecular strategies attenuating positional effects in lentiviral vectors carrying multiple genes 195
p21(Waf1/Cip1) and p53 are downstream effectors of protein kinase C delta in tumor suppression and differentiation in human colon cancer cells 194
Azithromycin: mechanisms of action and their relevance for clinical applications. 193
Finafloxacin for the treatment of urinary tract infections 193
Use of the UPOINT chronic prostatitis/chronic pelvic pain syndrome classification in European patient cohorts: sexual function domain improves correlations. 193
α-blockers and antibiotics, alone or in combination, improve symptoms in men with chronic prostatitis/chronic pelvic pain syndrome. 191
Antimicrobial therapy for chronic bacterial prostatitis. 190
Prevalence of erectile and ejaculatory dysfunction in men with chronic prostatitis/chronic pelvic pain syndrome 190
National institute of health chronic prostatitis symptom index (CPSI) symptom evaluation in patients with chronic prostatitis / chronic pelvic pain syndrome - A multinational study in 1,563 patients 189
Macrolides for the treatment of chronic bacterial prostatitis: an effective application of their unique pharmacokinetic and pharmacodynamic profile (Review). 188
Semen analysis in chronic bacterial prostatitis: diagnostic and therapeutic implications. 187
FRAIL scale as a predictor of complications and mortality in older patients undergoing reconstructive surgery for non-melanoma skin cancer 187
A switch therapy protocol with intravenous azithromycin and ciprofloxacin combination for severe, relapsing chronic bacterial prostatitis: a prospective non-comparative pilot study. 184
Inflammatory cues acting on the adult intestinal stem cells and the early onset of cancer (Review) 183
Efficacy of repeated cycles of combination therapy for the eradication of infecting organisms in chronic bacterial prostatitis 183
A polymorphism in the promoter region of Ku70/XRCC6, associated with breast cancer risk and oestrogen exposure. 183
Emerging second-line therapies for advanced, androgen deprivation-refractory prostate cancer in the post-docetaxel setting 182
Structure and function of the extraembryonic membrane persisting around the larvae of the parasitoid Toxoneuron nigriceps. 181
INTERACTION OF CU(II) AND CU(II)-ANTHRACYCLINE COMPLEXES WITH PROTEIN-KINASE-C - SPECTROMAGNETIC ASSESSMENT OF THE INHIBITORY EFFECT 179
Leech responses to tissue transplantation 175
Prevention and modulation of aminoglycoside ototoxicity (Review) 175
Polymorphisms in nonhomologous end joining genes associated with breast cancer risk and chromosomal radiosensitivity. 174
Reply to: Clarification to provide further understanding of the conduct and design of TROPIC: A Phase 3 trial of cabazitaxel versus mitoxantrone in patients with metastatic castration-resistant prostate cancer 174
Multiparametric magnetic resonance imaging characteristics of normal, benign and malignant conditions in the prostate 174
Collagen organization in leech wound healing. 172
DIFFERENTIAL PHORBOL ESTER GROWTH MODULATION AND PROTEIN-KINASE-C ISOENZYME EXPRESSION IN RAT HEPATOMA-CELLS VS NON NEOPLASTIC RAT HEPATOCYTES 172
Chlamydia trachomatis infection is related to premature ejaculation in chronic prostatitis patients: Results from a cross-sectional study 171
PROTECTIVE EFFECTS OF SPIN-TRAPPING AGENTS ON ADRIAMYCIN-INDUCED CARDIOTOXICITY IN ISOLATED RAT ATRIA 170
Resistance of human leukemic cell lines to 1-beta-D-arabinofuranosylcytosine: characterization of an experimental model 168
Emerging drugs for bacterial urinary tract infections. 168
Phosphatidylethanolamine N-methyltransferase 2 and CTP-phosphocholine cytidylyltransferase expressions are related with protein kinase C isozymes in developmental liver growth 167
Growth factors and chemokines: a comparative functional approach between invertebrates and vertebrates. 167
A switch therapy protocol with intravenous azithromycin and ciprofloxacin combination for severe, relapsing chronic bacterial prostatitis: a prospective non-comparative pilot study. 166
PROTEIN-KINASE-C ISOZYMES DURING LIVER-REGENERATION 164
PROTEIN-KINASE-C ISOZYME PATTERN IN LIVER HYPERPLASIA 163
Hypoxia as a risk factor for doxorubicin-induced cardiotoxicity: a NMR evaluation. 163
Effect of trimetazidine on early and delayed doxorubicin myocardial toxicity. 163
Topographic and quantitative relationship between prostate inflammation, proliferative inflammatory atrophy and low-grade prostate intraepithelial neoplasia: A biopsy study in chronic prostatitis patients 163
THE INHIBITORY EFFECT OF CU(II) ON PROTEIN-KINASE-C IS ENHANCED BY ANTHRACYCLINES - AN ESR STUDY 162
Effect of doxorubicin on calcium receptors of myocardial cells. 162
Risk factors analysis in patients with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) from Finland, Germany, Italy and Switzerland: Results of a multinational observational study 162
Early suppression of immune response in Heliothis virescens larvae by the endophagous parasitoid Toxoneuron nigriceps 162
Eradication of unusual pathogens by combination pharmacological therapy is paralleled by improvement of signs and symptoms of chronic prostatitis syndrome 160
Re: Samplaski et al.: Inclusion of erectile domain to UPOINT phenotype does not improve correlation with symptom severity in men with chronic prostatitis/chronic pelvic pain syndrome. (Urology 2011;78:653-658). 160
Chlamydia trachomatis versus common uropathogens as a cause of chronic bacterial prostatitis: Is there any difference? Results of a prospective parallel-cohort study 159
Reduction of PSA values by combination pharmacological therapy in patients with chronic prostatitis: implications for prostate cancer detection. 158
Wound repair in Hirudo medicinalis: phases and response modulation 157
ANALYSIS OF CALCIUM-DEPENDENT PROTEIN-KINASE-C ISOENZYMES IN INTRINSICALLY RESISTANT CLONED LINES OF LOVO CELLS - REVERSAL OF RESISTANCE BY KINASE INHIBITOR 1-(5-ISOQINOLINYLSULFONYL) 2-METHYLPIPERAZINE 157
PARTIAL-PURIFICATION OF PROTEIN-KINASE-C ISOENZYMES FROM RAT-LIVER 157
VEGF stimulates angiogenesis in Hirudo medicinalis. 157
Levofloxacin for NIH Category II Chronic Bacterial Prostatitis: A Real-Life Study 157
Resistance of uropathogens to antibacterial agents: Emerging threats, trends and treatments 156
Multidisciplinary approach to prostatitis 155
THE ACTIVITY OF A BETA-SUBTYPE OF PROTEIN-KINASE-C PURIFIED FROM NUCLEI OF HUMAN NEUTROPHILS IS ENHANCED BY TREATMENT WITH PHORBOL 12-MYRISTATE 13-ACETATE 153
Comparative analysis of immune responses and cytokine profiles elicited in rabbits by the combined use of recombinant fowlpox viruses, plasmids and virus-like particles in prime-boost vaccination protocols against SHIV 153
Distinctive cellular roles for novel protein kinase C isoenzymes 153
The radiosensitizing effect of Ku70/80 knockdown in MCF10A cells irradiated with X-rays and p(66)+Be(40) neutrons. 153
Leeches: Immune response, angiogenesis and biomedical applications 152
Hematopoietic cell formation in leech wound healing. 152
Hirudo medicinalis: a new model system for testing activators and inhibitors of angiogenesis 151
The association between prostatitis and prostate cancer. Systematic review and meta-analysis 151
Current knowledge of the potential links between inflammation and prostate cancer 151
Collagen reorganization in leech wound healing. 150
Antimicrobials in urogenital infections. 150
Herbal medicines for urinary stone treatment. A systematic review 148
Totale 20.634
Categoria #
all - tutte 121.019
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 121.019


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021461 0 0 0 0 0 0 0 0 0 0 0 461
2021/20221.970 190 191 128 173 31 99 82 152 258 240 154 272
2022/20232.265 262 122 235 199 170 488 3 284 285 79 75 63
2023/20244.839 675 731 765 812 905 256 60 109 148 118 117 143
2024/20254.058 136 145 605 134 184 221 176 303 417 422 404 911
2025/20268.054 608 494 440 1.054 749 468 1.580 558 829 606 444 224
Totale 31.706